Investing

NanoViricides : NNVC

NNVC

Stock Data

$1.30

$0.06 (4.84%)

Asset Type

Common Stock

Exchange

NYSE MKT

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

NanoViricides, Inc., a nanobiopharmaceutical company, discovers, develops and markets drugs for the treatment of viral infections. The company is headquartered in Shelton, Connecticut.

All NanoViricides Articles

1 Article

Chris Lange | Mar 9, 2020 at 10:34 AM EDT

How Coronavirus Stocks Are Handling Monday’s Market Meltdown

24/7 Wall St. has tracked some stocks that either are defensive in general or are defying Monday's big drop because…